fluorescein has been researched along with Carcinoma, Renal Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amato, RJ; Carnahan, N; Ellis, PR; Low, PS; Lu, Y; Mohlere, V; Shetty, A | 1 |
Brawanski, A; Hohenberger, C; Höhne, J; Proescholdt, M; Riemenschneider, MJ; Schebesch, KM; Wendl, C | 1 |
1 trial(s) available for fluorescein and Carcinoma, Renal Cell
Article | Year |
---|---|
A Phase I/Ib study of folate immune (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) with interferon-α and interleukin-2 in patients with renal cell carcinoma.
Topics: Adult; Aged; Cancer Vaccines; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Fluorescein; Folic Acid; Haptens; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome | 2014 |
1 other study(ies) available for fluorescein and Carcinoma, Renal Cell
Article | Year |
---|---|
Fluorescein sodium-guided resection of cerebral metastases-an update.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorescein; Fluorescent Dyes; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm, Residual; Neurosurgical Procedures; Postoperative Complications; Supratentorial Neoplasms | 2017 |